US 11397184
Selection of patients for combination therapy
granted A61KA61K31/4406A61K31/5685
Quick answer
US patent 11397184 (Selection of patients for combination therapy) held by Syndax Pharmaceuticals, Inc. expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syndax Pharmaceuticals, Inc.
- Grant date
- Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4406, A61K31/5685, A61K39/3955, A61K45/06